Not applicableStudy completedNCT06005337What this trial is testingSupporting Parents to Choose WiselyWho this might be right forCommon ColdPharyngitisAcute Otitis Media+4 more University of Alberta 174
Early research (Phase 1)Study completedNCT01319864What this trial is testingPOETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric PatientsWho this might be right forRelapsed/Refractory AMLRelapsed/Refractory ALLSecondary AML/MDS+3 more Seattle Children's Hospital 20
Not applicableLooking for participantsNCT06452732What this trial is testingUsing Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AMLWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Peking University People's Hospital 283
Not applicableLooking for participantsNCT06866873What this trial is testingCD-19 CAR-T Cell for Pediatric ALL or LymphomaWho this might be right forLymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric Hong Kong Children's Hospital 18
Not applicableStudy completedNCT02847130What this trial is testingIdentifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric OncologyWho this might be right forAcute Lymphoblastic LeukemiaB-Cell Non-Hodgkin LymphomaChildhood Acute Myeloid Leukemia+5 more Children's Oncology Group 530
Testing effectiveness (Phase 2)UnknownNCT03825367What this trial is testingNivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AMLWho this might be right forAML, Childhood Therapeutic Advances in Childhood Leukemia Consortium 13
Early research (Phase 1)Study completedNCT00079404What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaWho this might be right forAcute Undifferentiated LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid Leukemia+2 more National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Study completedNCT03825887What this trial is testingNalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer PatientsWho this might be right forAcute Myeloid LeukemiaStem Cell Leukemia Children's Cancer Hospital Egypt 57357 80
Not applicableUnknownNCT06026839What this trial is testingLongitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing FactorsWho this might be right forThalassemia MajorAcute Leukemia Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT01920737What this trial is testingA Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Ended earlyNCT00866281What this trial is testingThe Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 22
Early research (Phase 1)Study completedNCT00022451What this trial is testingTipifarnib in Treating Young Patients With Refractory LeukemiaWho this might be right forLeukemia National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT00460421What this trial is testingDose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCTWho this might be right forLeukemia Swedish Orphan Biovitrum 27
Early research (Phase 1)Study completedNCT00077467What this trial is testingBortezomib in Treating Young Patients With Refractory or Recurrent LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT01411267What this trial is testingAC220 for Children With Relapsed/Refractory ALL or AMLWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, Childhood Therapeutic Advances in Childhood Leukemia Consortium 24
Testing effectiveness (Phase 2)Study completedNCT03792633What this trial is testingStudy of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALLWho this might be right forAcute Lymphoblastic Leukemia University of Pennsylvania 106
Early research (Phase 1)Looking for participantsNCT06173518What this trial is testingCD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)Who this might be right forRelapsed or Refractory B Cell Acute Lymphoblastic LeukemiaRelapsed or Refractory B Cell Non-Hodgkin Lymphoma Autolus Limited 30
Not applicableActive Not RecruitingNCT05774990What this trial is testingStudy Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia TreatmentWho this might be right forLeukemia, Myeloid, AcuteAcute Lymphoblastic Leukemia University of Southern Denmark 800
Early research (Phase 1)Study completedNCT04996160What this trial is testingPalbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia, PediatricRelapsed Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia Tanja Andrea Gruber 2